Buscar
Abbott Laboratories
ABTAñadir a la lista de seguimiento
100.750USD
0.0000.00%
Cierre 07-23 16:00（ET）Cotizaciones retrasadas 15 min
174.96BCap. mercado
27.96P/E TTM
Más Datos de Abbott Laboratories Compañía
Abbott Laboratories is a global healthcare company. The Company’s principal business is the discovery, development, manufacture, and sale of a broad and diversified line of healthcare products. Its segments include Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. Established Pharmaceutical Products segment is engaged in the international sales of a broad line of branded generic pharmaceutical products. Diagnostic Products segment is involved in the worldwide sales of diagnostic systems and tests for blood banks, hospitals, commercial laboratories and alternate-care testing sites. Nutritional Products segment is engaged in the worldwide sales of a broad line of adult and pediatric nutritional products. Medical Devices segment is involved in the worldwide sales of rhythm management, electrophysiology, heart failure, vascular, structural heart, neuromodulation and diabetes care products. It serves people in more than 160 countries.
Información de Abbott Laboratories
Símbolo de cotizaciónABT
Nombre de la empresaAbbott Laboratories
Fecha de salida a bolsaApr 06, 2073
Director ejecutivoFord (Robert B)
Número de empleados114000
Tipo de seguridadOrdinary Share
Fin del año fiscalApr 06
Dirección100 Abbott Park Road
CiudadABBOTT PARK
Bolsa de valoresNASDAQ OMX NASDAQ Basic NYSE
PaísUnited States of America
Código postal60064-3500
Teléfono12246676100
Sitio Webhttps://www.abbott.com
Símbolo de cotizaciónABT
Fecha de salida a bolsaApr 06, 2073
Director ejecutivoFord (Robert B)
Ejecutivos de Abbott Laboratories
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
90.41K
+20.44%
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
76.57K
-0.35%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
71.54K
+28.74%
Dr. Robert J. Alpern, M.D.
Dr. Robert J. Alpern, M.D.
Independent Director
Independent Director
40.80K
--
Ms. Sally E. Blount, Ph.D.
Ms. Sally E. Blount, Ph.D.
Independent Director
Independent Director
36.34K
+6.29%
Mr. John G. Stratton
Mr. John G. Stratton
Independent Director
Independent Director
23.32K
+8.58%
Ms. Michelle A. Kumbier
Ms. Michelle A. Kumbier
Independent Director
Independent Director
18.00K
+12.70%
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. Daniel J. Starks
Mr. Daniel J. Starks
Independent Director
Independent Director
6.75M
+0.18%
Mr. Daniel Gesua Sive Salvadori
Mr. Daniel Gesua Sive Salvadori
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
Executive Vice President, Group President - Established Pharmaceuticals and Nutritional Products
146.38K
-0.60%
Ms. Mary K. Moreland
Ms. Mary K. Moreland
Executive Vice President - Human Resources
Executive Vice President - Human Resources
104.29K
-0.59%
Ms. Lisa D. Earnhardt
Ms. Lisa D. Earnhardt
Executive Vice President, Group President - Medical Devices
Executive Vice President, Group President - Medical Devices
90.41K
+20.44%
Mr. Louis H. (Lou) Morrone
Mr. Louis H. (Lou) Morrone
Executive Vice President - Core Diagnostics
Executive Vice President - Core Diagnostics
76.57K
-0.35%
Mr. Philip P. Boudreau
Mr. Philip P. Boudreau
Chief Financial Officer, Executive Vice President - Finance
Chief Financial Officer, Executive Vice President - Finance
71.54K
+28.74%
Preguntas frecuentes
¿Quiénes son los cinco principales accionistas de Abbott Laboratories?
Los cinco principales accionistas de Abbott Laboratories son: Mr. Daniel J. Starks
¿Cuántas instituciones poseen acciones de Abbott Laboratories (ABT)?
A fecha de 2026Q1, 4859 instituciones poseen acciones de Abbott Laboratories, con un valor de mercado combinado de aproximadamente 1.25B, lo que representa el 71.75% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en -187252308.00.
¿Cuál es la mayor fuente de ganancias de Abbott Laboratories?
El 2026Q1, el segmento empresarial Diabetes Care generó la ganancia más alta para Abbott Laboratories, ascendiendo a 8.00B y representando el 18.04% de la ganancia total.